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INTRODUCTION: S. aureus is one of the main agents of nosocomial infection and is sometimes difficult to treat with currently 
available active antimicrobials. 
PURPOSE: To analyze the prevalence of methicillin-susceptible S.aureus (MSSA) and methicillin-resistant S. aureus (MRSA) 
as well as the MRSA antimicrobial susceptibility profile isolated in the saliva of health professionals at a large public education 
hospital. 
MATERIALS AND METHODS: The project was approved by the research and ethics committee of the institution under study. 
Three samples of saliva from 340 health professionals were collected. The saliva analysis used to identify S. aureus was based 
on mannitol fermentation tests, catalase production, coagulase, DNAse, and lecithinase. In order to detect MRSA, samples were 
submitted to the disk diffusion test and the oxacillin agar screening test . In order to identify the minimum inhibitory concentration, 
the Etest® technique was used. 
RESULTS: The prevalence of MSSA was 43.5% (148/340), and MRSA was 4.1% (14/340). MRSA detected by the diffusion 
disk test, was 100% resistant to penicillin and oxacillin, 92.9% resistant to erythromycin, 57.1% resistant to clindamycin, 42.9% 
resistant to ciprofloxacin and 57.1% resistant to cefoxetin. 
CONCLUSION: This subject is important for both the education of health professionals and for preventative measures. Standard 
and contact-precautions should be employed in professional practice. 
KEYWORDS: S. aureus; Methicillin resistance; Occupational risk; Hospital infection. Exposure to biological agents.
INTRODUCTION
S. aureus is one of the main agents responsible for 
infections. Its virulence and ability to acquire resistance to 
antimicrobial agents mean results in a serious worldwide 
problem for hospitals and health professionals. 
About 20% of the human population carries at least 
one type of S. aureus. Studies show that higher rates 
of colonization by this organism are found in health 
professionals, intravenous drug users, and insulin-dependent 
diabetic patients with skin diseases or with venous catheter 
use for long periods.1 
MRSA is found endemically in many hospitals. The 
severity of resulting diseases and high costs of health care 
justify an investment in prevention and control guidelines. 
It is therefore imperative for health services to carry out 
systematic MRSA surveillance and disseminate the findings 
to health professionals.2 
The resistance of S. aureus to antimicrobial agents can be 
encoded by both chromosomes and plasmids. There are three 
distinct mechanisms of methicillin resistance: beta-lactamase 
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hyperproduction, the presence of a penicillin-binding protein 
(PBP) called PBP 2a, and altered ability to bind to PBP.3 
Thus, a single specimen can use these different mechanisms 
for methicillin resistance, and the mechanisms can even 
interact among themselves.4
Since 1990, MRSA, which was exclusively considered 
a hospital pathogen (HA-MRSA), has been isolated from 
individuals in the community with no identified risk factors 
and no epidemiological relation to the community-associated 
MRSA (CA-MRSA.).5 
The management of hospital and community infections 
has become increasingly difficult because both HA-MRSA 
and the CA-MRSA have been isolated in both locations.
Most colonized health professionals are transient carriers 
but may become persistent carriers, especially when they 
have skin lesions. Thus, the identification and treatment 
of colonized health professionals can reduce the incidence 
of MRSA, as unidentified colonized patients can act as a 
reservoir in endemic situations.6 
OBJECTIVE
To determine the prevalence of MSSA and MRSA, 
as well as the MRSA antimicrobial susceptibility profile 
isolated in the saliva of health professionals at a large public 
education hospital. 
MATERIALS AND METHODS
This was a cross-sectional study conducted at a large 
public hospital, in Santo Andre, São Paulo, Brazil, from 
August 2006 to June 2008. The hospital served as the site 
for the collection of material (saliva) at three different time 
points and for the distribution of questionnaires. 
The following inclusion criteria were used: physicians, 
registered nurses, nursing technicians or nursing assistants 
who were full-time professionals during the data collection 
period, were not using antimicrobials for 30 days prior to 
the collection, gave their consent to participate, provided 
three samples of saliva collected at established times, and 
worked in the intensive care units, medical clinic, surgery, 
gynecology-obstetrics, surgery centers, day hospital or 
emergency rooms. 
From a sample of 374 nursing and gynecology 
professionals, 34 were excluded due to partition or removal 
from the institution. Of the remaining 340 participants, 
22 were gynecologists and obstetricians, and 318 were 
professionals from the nursing staff (42 registered nurses, 
99 nursing technicians, 177 nursing assistants). 
In order to carry out this investigation, the Resolution of 
the National Council of Ethics in Research (CONEP) No. 
196, of 1996, and No. 251, of 1997 were followed.7 This 
project was approved by the ethics and research committee 
of the Ethics and Research Committee of the College of 
Medicine of ABC, according to CEP/ FMABC protocol, No 
242/2006. 
The subjects were informed about the research objectives 
as well as the anonymity and confidentiality of the 
information provided. Those who agreed to participate in the 
investigation signed the free and informed consent form. 
Data Collection
The saliva was collected in 12 ml sterile tapered plastic 
tubes, capped, packaged in a styrofoam box and sent to the 
Bacteriology Laboratory (IPTSP / UFG). The collection of 
the second and third samples was conducted similarly, at 
time points of two and four months.
A semi-structured questionnaire testing the following 
areas was used: occupational category, gender, age, sector 
and working shift, time of work in the institution and 
employment at another institution.
Laboratory procedures: isolation and identification of 
S. aureus 
The identification of S. aureus was based on mannitol 
fermentation tests, catalase, coagulase, DNAse and 
lecithinase production.8 The S. aureus identified were 
submitted to the diffusion disk test.9 
Oxoid disks (Basingstoke, England) were used with the 
following antimicrobials: oxacillin, cefoxitin, erythromycin, 
clindamycin, tetracycline, rifampin, ciprofloxacin, 
gentamicin, sulfamethoxazole-trimetoprin, vancomycin, 
penicillin, linezolid, and mupirocin. The susceptibility 
and resistance were compared with the standardized halo 
table by CLSI. Isolates with intermediate susceptivity were 
considered resistant. Quality control was performed with the 
ATCC standard strains of S. aureus 25923 and 29213.9 
In order to detect the resistance of S. aureus to 
methicillin, the oxacillin agar screening test was performed 
in Petri dishes containing Mueller-Hinton agar supplemented 
with 4% NaCl and oxacillin 6 µg/ml. The growth of a colony 
was indicative of resistance to methicillin.9 
The strains of Staphylococcus that were resistant to 
oxacillin on the disk diffusion test were then tested in the 
minimum inhibitory concentration (MIC) by Etest®. The 
bacteria were cultured on blood agar (Muller Hinton Agar plus 
5% sheep blood) and incubated at 37oC for 24 hours. After 
this incubation period, a bacterial suspension was prepared 
in sterile saline solution, equivalent to 0.5 on the McFarland 
scale (1x108 CFU/ml). This suspension was poured on a plate 
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containing Mueller-Hinton agar plus 2% NaCl. After drying 
the inoculum on the surface of the agar, the Etest tape was 
placed using forceps, as per manufacturer recommendation 
(AB Biodisk, Solna, Switzerland). The plate was subsequently 
incubated at 35°C. Readings were performed after 24 hours.10 
The standard lineage used for quality control was S. aureus 
ATCC 29213. The MIC by Etest shows the concentration 
of antibiotics as indicated in the tape at the intersection of 
the ellipse and bacterial growth inhibition. Results were 
interpreted according to the CLSI.10 
Organization and data analysis
The database was structured and analyzed using the 
Statistical Package Social Science program, version 15.0 
for Windows. 
RESULTS
Of 340 professional participants in the study, 22 (6.5%) 
were gynecologists and obstetricians, 42 (12.3%) registered 
nurses, 99 (29.1%) nursing technicians and 177 (52.1%) 
nursing assistants. Of these, 256 (75.3%) were female and 
84 (24.7%) male. The age of participants ranged from 19 to 
60 years, with an average of 34.6 years. 
With regard to the workplace, surgical clinic admittance 
units (18.5%), intensive care units (13.8%) and nursery and 
neonatal intensive care units (11.5%) comprised the largest 
number of work places followed by the surgery center 
(10.3%), clinical medicine units for carriers of infectious 
diseases (9.7%) and emergency unit/day hospital (9.7%). 
Other sites were represented by a smaller number of 
professionals: obstetrics clinic and center (8.8%), pediatric 
and coronary intensive care unit (7.6%), obstetrics and 
gynecology (6.5%) and pediatrics (3.5%).
The working time in the institution ranged from one 
to 60 months, with an average of 26 months. Regarding 
the working hours, it is notable that nursing professionals 
worked 36 hours per week and physicians worked in shifts 
ranging from 12 to 24 hours per week. Regarding the 
work shift, the highest number of professionals work on a 
fixed scale, with 164 (48.2%) individuals working the day 
Table 1 - Distribution of participants according to professional category and colonization by S. aureus, 2007-2008
Professional category Not colonized Colonized TOTAL
F % f % f %
Nursing Assistant 89 50.0 (42.4-57.6) 88 54.3 (46.3-62.2) 177 52.1 (46.6-57.5)
Nursing Technician 54 30.3 (23.7-37.7) 45 27.8 (21.0-35.3) 99 29.1 (24.4-34.3)
Registered nurse 25 14.0 (9.3-20.0) 17 10.5 (6.2-16.3) 42 12.3 (9.1-16.4)
Physician 10 5.7 (2.7-10.1) 12 7.4 (3.9-16.9) 22 6.5 (4.2-9.8)
Total 178 100 162 100 340 100
(95% confidence limits)
Table 2 - Distribution of participants according to working sector and colonization by S. aureus, 2007-2008
Working Sector Not colonized Colonized TOTAL
f % f % f %
Surgery 32 18.0 (12.6-24.4) 31 19.1 (13.4-26.0) 63 18.5 (14.6-23.2)
ICU 28 15.8 (10.7-21.9) 19 11.7 (7.2-17.7) 47 13.8 (10.4-18.1)
Nursery and neonatal ICU 18 10.1 (6.1-15.5) 21 13.0 (8.2-19.1) 39 11.5 (8.4-15.5)
Surgical center/PAR 16 9.0 (5.2-14.2) 19 11.7 (7.2-17.7) 35 10.3 (7.4-14.1)
Medical clinic 18 10.1 (6.1-15.5) 15 9.3 (5.3-14.8) 33 9.7 (6.9-13.5)
Day hospital and emergency room 14 7.9 (4.4-12.8) 19 11.7 (7.2-17.7) 33 9.7 (6.9-13.5)
Obstetrics clinic and center 17 9.5 (5.7-14.9) 13 8.0 (4.3-13.3) 30 8.8 (6.1-12.5)
Coronary + pediatric ICU 17 9.5 (5.7-14.9) 09 5.6 (2.6-10.3) 26 7.6 (5.2-11.1)
Gynecology and obstetrics 10 5.6 (2.7-10.1) 12 7.4 (3.9-12.6) 22 6.5 (4.2-9.8)
Pediatrics 08 4.5 (2.0-8.7) 04 2.5 (0.7-6.2) 12 3.5 (1.9-6.2)
Total 178 100 162 100 340 100
Label – ICU: Intensive care unit; PAR: Post-anesthesia recovery, (95% confidence limits)
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shift, 155 (45.6%) the night shift, and 6 (1.8%) a rotational 
schedule. Fifteen individuals (4.4%) did not answer this 
question.
A total of 113 (33.2%) respondents maintained ties with 
other health institutions and have an additional work load 
ranging from six to 48 hours per week. 
Health professionals and S. aureus colonization 
Of the 340 professionals from whom three saliva samples 
were collected, S. aureus was isolated from at least one 
sample in 162 individuals (47.6%.) Therefore, the prevalence 
of S. aureus was 47.6% (162/340.) 
The demographic and professional characterization of 
subjects, ranked according to colonization, is presented 
in Tables 1-3. Regarding the professional category of the 
colonized subjects, 88 (54.3%) were nursing auxiliaries, 
45 (27.8%) were nursing technicians, 17 (10.5%) were 
registered nurses and 12 (7.4%) were physicians. Females 
(72.2%) between the ages of 19 and 39 years (69.7%) 
prevailed among colonized professionals. 
The following work sectors stand out in terms of the 
proportion of colonized subjects: surgical clinics (19.1%), 
nursery and neonatal intensive care unit (13.0%), intensive 
care unit (11.7%), surgical center (11.7%) day-hospital and 
emergency (11.7%). 
Regarding the working shift, 46.3% of workers who were 
carriers of S. aureus were from the day shift and 45.7% from 
the night shift. Of the 113 with secondary employment, 52 
(32.1%) were colonized.
Health professionals and colonization by MRSA 
Table 4 highlights the characteristics of professionals 
colonized by MRSA according to their professional category, 
gender, sector of employment, length of employment at the 
Table 3 - Distribution of participants according to professional and personal characterization and colonization by S. aureus, 
2007-2008
Variables Not colonized (n = 178) Colonized (n = 162) TOTAL (n = 340)
F % f % f %
Gender
Female 139 78.1 (71.3-83.9) 117 72.2 (64.7-79.0) 256 75.3 (70.4-79.8)
Male 39 21.9 (16.1-28.7) 45 27.8 (21.0-35.3) 84 24.7 (20.3-29.7)
Age (years)
19 to 29 50 28.1 (21.6-35.3) 59 36.4 (29.0-44.3) 109 32.1 (27.2-37.3)
30 to 39 76 42.7 (35.3-50.3) 54 33.3 (26.1-41.2) 130 38.2 (33.1-43.7)
40 to 49 44 24.7 (18.6-31.7) 44 27.2 (20.5-34.7) 88 25.9 (21.4-30.9)
50 to 59 08 4.5 (2.0-8.7) 05 3.1 (1.0-7.1) 13 3.8 (2.1-6.6)
Length of employment in the institution (months)
01 to 11 38 21.3 (15.6-28.1) 37 22.8 (16.6-30.1) 75 22.1 (17.8-26.9)
12 to 23 33 18.5 (13.1-25.0) 29 17.9 (12.3-24.7) 62 18.2 (14.4-22.8)
24 to 35 36 20.2 (14.6-26.9) 25 15.4 (10.2-21.9) 61 17.9 (14.1-22.5)
36 to 47 47 26.4 (20.1-33.5) 41 25.3 (18.8-32.7) 88 25.9 (21.4-30.9)
48 to 60 13 7.3 (3.9-12.2) 12 7.4 (3.9-12.6) 25 7.4 (4.9-10.8)
No answer 11 6.2 (3.1-10.8) 18 11.1 (6.7-17.0) 29 8.5 (5.9-12.1)
Work shift 
Day 89 50.0 (42.4-57.6) 75 46.3 (38.4-54.3) 164 48.2 (42.8-53.7)
Night 81 45.5 (38.0-53.1) 74 45.7 (37.8-53.7) 155 45.6 (40.2-51.0)
Rotating schedule 02 1.1 (0.1-4.0) 04 2.5 (0.7-6.2) 06 1.8 (0.7-4.0)
No answer 06 3.4 (1.2-7.2) 09 5.6 (2.6-10.3) 15 4.4 (2.6-7.3)
Multiple Employment
Yes 61 34.3 (27.3-41.7) 52 32.1 (25.0-39.9) 113 33.2 (28.3-38.6)
No 112 62.9 (55.4-70.0) 101 62.3 (54.4-69.8) 213 62.6 (57.3-67.8)
No answer 05 2.8 (0.9-6.4) 09 5.6 (2.6-10.3) 14 4.1 (2.4-7.0)
(95% confidence limits)
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investigated hospital and other institutional bonds. In terms 
of category, the following were colonized by MRSA: nine 
nursing assistants and five nursing technicians. In terms of 
gender, 11 were female and three were males between the 
ages of 25 and 49 years, with the majority (42.9%) between 
25 and 29 years. Regarding the labor sector, four participants 
worked in the surgical clinic, four in the obstetrics clinic and 
center, three in the intensive care unit, two in the nursery 
and neonatal intensive care unit, and one in the surgical 
center. No professional working in the pediatrics unit or in 
the medical clinic and day hospital/emergency room was 
identified to be colonized by MRSA. The prevalence of 
MRSA was 4.1% (14/340).
The number of colony-forming units (CFU) of MRSA 
ranged from 50 to 10,500.
Of the 14 professionals colonized by MRSA, 7 had 
been working at the institution less than 12 months. Four 
individuals were working between 37 and 60 months; nine 
individuals worked in the institution during the day shift and 
six had a second employment.
Antimicrobial susceptibility of MRSA
For the disc diffusion test, MRSA was cultured 
in agar-screening oxacillin (6 µg) supplemented with 
sodium chloride at 4.0%. MRSA grown under these 
conditions were subjected to the Etest® technique, and 
14 colonies showed a minimum inhibitory concentration 
greater than 256 µg/ml. The MRSA susceptibility profile 
of the saliva of health professionals is presented in 
Table 5. This table indicates resistance to oxacillin as 
well as penicillin (100%). A total of 92.9% presented 
resistance to erythromycin, 57.1% to clindamycin, 57.1% 
to cefoxitin, 42.9% to ciprofloxacin, 7.1% to gentamicin 
and 7.1% to trimethoprim-sulfamethoxazole. All MRSA 
(100%) presented susceptibility to tetracycline, rifampin, 
vancomycin, linezolid and mupirocin. 
DISCUSSION
It is necessary to detect MRSA in healthy individuals. 
These individuals can act as carriers and thus as a potential 
source of microorganisms, which are important for the 
epidemiology and pathogenesis of hospital infections.1,11 
The prevalence of S. aureus in this study was 47.6% 
(162/340). The isolation of S. aureus from health 
professionals varied according to the professional category, 
working sector and levels of adherence to specific 
precautions against multi-resistant microorganisms. 
Studies in different countries have indicated the prevalence 
of individuals colonized by S.aureus; in these studies, the 
micorganisms were isolated from the nostrils. The prevalence 
of S. aureus in the anterior nostril of 975 health professionals 
was 33.4%, where 262 (27.2%) had MSSA and 60 (6.2%) 
had MRSA.12 In another study, the isolation rate of S. aureus 
in health professionals was 33.8%.13 
The prevalence of MRSA varies between institutions 
and geographic areas. Most hospitals face the challenge of 
controlling MRSA. The increasing incidence of MRSA has 
been well documented among health professionals.14 
Table 4 - Characterization of health professionals from a public education hospital who were colonized by MRSA (n=14), 
2007-2008 
Subject Professional category Gender Working Sector Working time (months) Working at other institution
009 nursing assistant Female Surgery 02 No
026 nursing assistant Female Obstetric clinic/center 21 No
029 nursing assistant Female Obstetric clinic/center 10 No
073 nursing technician Female Nursery/neonatal ICU 05 Yes
118 nursing assistant Female Surgery 12 No
132 nursing assistant Female Surgical center/PAR 31 No
155 nursing assistant Female Obstetric clinic/center 45 Yes
173  nursing technician Female Nursery/neonatal ICU 50 No
188 nursing technician Male ICU I and II 45 Yes
189 nursing assistant Male Surgery 44 No
198 nursing assistant Female Obstetric clinic/center 22 Yes
213 nursing assistant Male Surgery 04 Yes
221 nursing technician Female ICU I and II 04 No
276  nursing technician Female Pediatric and coronary ICU 04 Yes
Label – ICU: Intensive Care Unit; PAR: Post-Anesthesia Recovery
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An investigation in the Netherlands found 35% of 
health professionals to be carriers of MSSA and less than 
5% to be colonized by MRSA15. In Berlin, Germany a rate 
of 1.6%13 was identified. In a German trauma center with 
750 beds, samples were collected from the oropharynx of 
324 physicians and registered nurses, and the prevalence of 
MRSA was identified to be 5.3% and 36.4% of the identified 
S. aureus.16 
In the United States, the prevalence of MRSA was found 
to be 15% among employees of an emergency department17. 
Another investigation with 255 professional (physicians, 
registered nurses, social service) found that the prevalence 
of S. aureus was 31.8% and 13.6% for MRSA. MRSA was 
identified in the nursing staff.18 The prevalence of S. aureus 
was 28%, and MRSA 2%, in the nostrils of 200 former 
health employees of an American tertiary hospital.19 Among 
professionals who care for burn patients, a rate of 4.5% was 
detected in Rhode Island.6 
In Brazil, the data are still not enough. The estimated 
frequency of MRSA varies from 25% to 50%.14 A study 
in Goiânia found that 26.9% of health professionals were 
carriers of MRSA.20 In Curitiba-PR, the prevalence was 
60.9% (296/486,) with 12.7% (62/486) for MRSA and 
48.1% (234/486) for MSSA.21 
In the present study, 4.1% of health professionals were 
found to be MRSA carriers. A study that investigated 
an outbreak of MRSA found that 80.6% of cases were 
associated with strains from colonized health care 
professionals.22 
Another study, however, found an incidence of 50% 
colonization by S. aureus among professionals (296/592), 
where 38.7% were resistant to methicillin. The overall 
incidence of colonization ranged from 12.4% in the intensive 
care unit to 36.7% in clinical surgery.23 
Regarding the colonization of professionals by MRSA, 
various indices have been recorded, ranging from 2.6% 
to 38.7%.20,23-28 In a systematic review29 of 127 articles on 
colonization from January 1980 to March 2006, it was noted 
that although studies have differed in terms of methodology 
and the body site investigated, the average prevalence of 
MRSA was 4.6% among the 33,318 health professionals 
assessed, with 5.1% having an infection. Regarding the 
professional category, the prevalence of MRSA among the 
nursing staff was between 7.4% and 8.0%. 
In this study, MRSA was found exclusively in the 
nursing staff, including nursing technicians and assistants. 
No registered nurse or physician was infected or found to be 
a healthy carrier. 
The lack identification of MRSA among workers in 
the medical clinic, a location where infectious diseases 
(isolation) often occur, can be explained by the routine use 
of precautions. Another factor that should be considered 
is the increased risk of transmission for workers in the 
surgical center, obstetric clinics, neonatal intensive care unit 
and nursery, given the specific procedures and the patient 
conditions. 
Table 5 - Antimicrobial susceptibility profile detected by disk diffusion test for 14 MRSA-identified health professionals 
from a public education hospital, 2007-2008 
ID Oxa Pen Eri Cli Cip Cef Gen Sul Oxa 6µg
9 R R R R R R S S +
26 R R R R R S S S +
29 R R R S S R S S +
73 R R R R R R S S +
118 R R R R R R R R +
132 R R S S S R S S +
155 R R R R R S S S +
173 R R R S S S S S +
188 R R R R S S S S +
189 R R R S S S S S +
198 R R R S S R S S +
213 R R R S S R S S +
221 R R R R R R S S +
276 R R R R S S S S +
% R 100.0 100.0 92.9 57.1 42.9 57.1 7.1 7.1 100.0
Label: ID: identification of the subject; R: resistant, S: susceptible; oxa: oxacillin, Pen: penicillin, Eri: erythromycin, Cli: clindamycin, Cip: ciprofloxa-
cin, Cef: Cefoxitin, Gen: gentamicin, Sul: trimethoprim-sulfamethoxazole
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In Goiania, 26.9% of professionals with MRSA were 
identified to work in the medical intensive care unit, 19.2% 
in medical clinics, 15.4% in surgical intensive care units, 
15.4% in the surgical clinic, 15.4% in the gynecology-
obstetrics clinic, and 7.7% in surgery20. 
The identification of MRSA is considered to be a 
preventative strategy that allows the reduction of incidence. 
Several researchers have proposed laboratory methods aimed 
at optimizing the time of analysis in order to obtain sure 
results of the state of colonization by MRSA.11,30
Of the 14 MRSA isolates, 100% presented resistance to 
penicillin and oxacillin, 92.9% to erythromycin, 57.1% to 
clindamycin, 57.1% to cefoxitin and 42.9% to ciprofloxacin. 
In terms of resistance to different groups of antimicrobials, 
six MRSA isolates that demonstrated resistance to oxacillin 
also showed resistance to three other groups of antibiotics: 
erythromycin (macrolid), clindamycin (lincosamides) 
and ciprofloxacin (quinolone). This suggests resistance 
to macrolides, lincosamides and streptogramins (MLS), 
which are widely used for the treatment of staphylococcus 
infections. These antibiotics are chemically different, 
but share the same mechanism of action: inhibition of 
bacterial protein synthesis. The profile of multi-resistance is 
representative of MRSA clones from hospitals.
Two MRSA isolates were resistant to erythromycin and 
clindamycin. Their phenotype of susceptibility suggested 
origination from the community. These eight (57.1%) 
staphylococci can be classified as multi drug-resistant. 
Analysis of the profile of 14 strains of MRSA isolated 
from the vaginal secretions of pregnant women revealed 
five isolates phenotypes associated with the community; 
these phenotypes comprised susceptibility to ciprofloxacin, 
gentamicin, trimethoprim-sulfamethoxazole and clindamycin. 
Meanwhile, three MRSA isolates with hospital features that 
were resistant to gentamicin, ciprofloxacin and clindamycin 
were identified; four isolated were suggestive of the MLS31 
profile. 
There was a high rate (92.9%) of resistance to 
erythromycin in MRSA isolated from saliva. 
Among the lincosamides (lincomycin and clindamycin), 
clindamycin is the drug of choice for staphylococcus 
infections resistant to erythromycin, especially for skin 
and soft tissue infections. This further represents a safe 
alternative for patients allergic to penicillin. However, the 
inducible MLS resistance phenotype has led to clinical 
failure during treatment. In the present study, 61.16% of 
MRSA isolates were resistant to clindamycin, which limits 
therapeutic options. Of the 14 MRSA isolates tested, 44.4% 
were resistant to both erythromycin and clindamycin, which 
leads us to infer a resistance profile.32
Three related determinants, ermA, ermB and ermC, 
have been identified and thought to be responsible for 
the MLSB phenotype in staphylococci. The expression of 
this phenotype may be constitutive or inducible. When 
expression of the MBS phenotype it is constitutive, isolates 
are resistant to all macrolides, lincosamides and type B 
streptogramins. When the phenotype is induced, the isolates 
are resistant to macrolides with 14 and 15 atoms in the 
lactone ring. Macrolides with 16 atoms, lincosamides and 
streptogramins remain active. This resistance occurs due to 
the differences in MLS antibiotic inducing abilities. Thus, 
14 and 15 atoms in the macrolide are effective for inducing 
synthesis of metilases.33 It was found in this study that six 
(33.3%) MRSA isolates were resistant to erythromycin 
and susceptible to clindamycin; this may represent induced 
resistance to clindamycin. The 14 MRSA isolates were 
susceptible to tetracyclin, rifampin, vancomycin, linezolid 
and mupirocin. This may represent a favorable quality, as the 
antibiotics of choice for treatment of infections by MRSA 
are vancomycin and linezolid. Also, it should be emphasized 
that mupirocin is used to stop colonization.34 
In a previous analysis of 13 MRSA isolates with 
infections acquired in the community, all presented 
SCCmec type IV.35 These isolates demonstrated a profile 
of susceptivity to gentamicin, linezolid, mupirocin, 
trimethoprim-sulfamethoxazole, vancomycin, and beta-
lactam. These findings are similar to those found in this 
study. 
Several preventive measures have been recommended for 
the control of MRSA, such as prospective microbiological 
surveillance, contact precautions for colonized or infected 
patients, hand hygiene, cleaning of the environment, control 
of microbes, and the stoppage of colonization in colonized 
patients and professionals.34 
CONCLUSIONS
The prevalence of S. aureus among health professionals 
was 47.6% (162/340) and the prevalence of MRSA was 
4.1% (14/340). 
MRSA identified in 14 health professionals was 100% 
resistant to penicillin and oxacillin. Moreover, there were 
large degrees of resistance to erythromycin (92.9%), 
clindamycin (57.1%), ciprofloxacin (42.9%) and cefoxetin 
(57.1%).
S. aureus was classified in this study to be multi-resistant 
(57.1%) when it was resistant to two or three different 
groups of antimicrobials: erythromycin, clindamycin and 
ciprofloxacin. 
To assess the prevalence of MRSA among health 
professionals it is important to determine preventive 
measures in hospital infection and even morbidity. There is 
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